| Carbamazepine | Approved Investigational | CYP39A1 | 51302 |
upregulated | Carbamazepine results in increased expression of CYP39A1 mRNA | 6p12.3 | |
| Carbamazepine | Approved Investigational | CYP3A4 | 1576 |
upregulated | Carbamazepine results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Carbamazepine | Approved Investigational | CYP3A43 | 64816 |
upregulated | Carbamazepine results in increased expression of CYP3A43 mRNA | 7q22.1 | |
| Carbamazepine | Approved Investigational | CYP3A5 | 1577 |
upregulated | Carbamazepine results in increased expression of CYP3A5 mRNA | 7q22.1 | |
| Carbamazepine | Approved Investigational | CYP3A7 | 1551 |
upregulated | Carbamazepine results in increased expression of CYP3A7 mRNA | 7q22.1 | |
| Carbamazepine | Approved Investigational | CYP4F3 | 4051 |
upregulated | Carbamazepine results in increased expression of CYP4F3 mRNA | 19p13.12 | |
| Carbamazepine | Approved Investigational | DDIT3 | 1649 |
upregulated | Carbamazepine results in increased expression of DDIT3 mRNA | 12q13.3 | |
| Carbamazepine | Approved Investigational | EPHX1 | 2052 |
upregulated | Carbamazepine results in increased expression of EPHX1 mRNA | 1q42.12 | |
| Carbamazepine | Approved Investigational | ERBB2 | 2064 |
downregulated | Carbamazepine results in decreased expression of ERBB2 mRNA | 17q12 | |
| Carbamazepine | Approved Investigational | ESR1 | 2099 |
downregulated | Carbamazepine results in decreased expression of ESR1 mRNA | 6q25.1-q25.2 | |
| Carbamazepine | Approved Investigational | FADS2 | 9415 |
downregulated | Carbamazepine results in decreased expression of FADS2 mRNA | 11q12.2 | |
| Carbamazepine | Approved Investigational | GSTA1 | 2938 |
upregulated | Carbamazepine results in increased expression of GSTA1 mRNA | 6p12.2 | |
| Carbamazepine | Approved Investigational | GSTZ1 | 2954 |
upregulated | Carbamazepine results in increased expression of GSTZ1 mRNA | 14q24.3 | |
| Carbamazepine | Approved Investigational | HMGCR | 3156 |
downregulated | Carbamazepine results in decreased expression of HMGCR mRNA | 5q13.3 | |
| Carbamazepine | Approved Investigational | LDLR | 3949 |
downregulated | Carbamazepine results in decreased expression of LDLR mRNA | 19p13.2 | |
| Carbamazepine | Approved Investigational | MAOA | 4128 |
upregulated | Carbamazepine results in increased expression of MAOA mRNA | Xp11.3 | |
| Carbamazepine | Approved Investigational | MAOB | 4129 |
upregulated | Carbamazepine results in increased expression of MAOB mRNA | Xp11.3 | |
| Carbamazepine | Approved Investigational | NAT1 | 9 |
upregulated | Carbamazepine results in increased expression of NAT1 mRNA | 8p22 | |
| Carbamazepine | Approved Investigational | NAT2 | 10 |
upregulated | Carbamazepine results in increased expression of NAT2 mRNA | 8p22 | |
| Carbamazepine | Approved Investigational | NR1I2 | 8856 |
upregulated | Carbamazepine results in increased expression of NR1I2 mRNA | 3q13.33 | |
| Carbamazepine | Approved Investigational | NR1I3 | 9970 |
upregulated | Carbamazepine results in increased expression of NR1I3 mRNA | 1q23.3 | |
| Carbamazepine | Approved Investigational | NR3C1 | 2908 |
upregulated | Carbamazepine results in increased expression of NR3C1 mRNA | 5q31.3 | |
| Carbamazepine | Approved Investigational | NR3C2 | 4306 |
upregulated | Carbamazepine results in increased expression of NR3C2 mRNA | 4q31 | |
| Carbamazepine | Approved Investigational | PCSK9 | 255738 |
downregulated | Carbamazepine results in decreased expression of PCSK9 mRNA | 1p32.3 | |
| Carbamazepine | Approved Investigational | PLA2G4A | 5321 |
downregulated | Carbamazepine results in decreased expression of PLA2G4A mRNA | 1q31.1 | |